Dr. Ashley Crawley is a pharmacist who is specialized in Oncology in Little Rock, Arkansas. Patients can reach her at 8901 Carti Way, Little Rock or contact her on 501-906-3000. Active license number of Dr. Ashley Crawley is PD10802 for Oncology in Arkansas. Dr. Ashley Crawley is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Ashley Crawley speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Ashley Crawley
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
8901 Carti Way, Little Rock, Arkansas, 72205-6523
Phone:
501-906-3000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Ashley Crawley are as mentioned below.
NPI Number:
1053066787
NPI Enumeration Date:
22 Feb, 2022
NPI Last Update On:
22 Feb, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Ashley Crawley are as mentioned below.
Specialization
License Number
State
Status
Oncology
PD10802
Arkansas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8901 Carti Way, Little Rock, Arkansas
Zip:
72205-6523
Phone Number:
501-906-3000
Fax Number:
--
Patients can reach Dr. Ashley Crawley at 8901 Carti Way, Little Rock, Arkansas or can call on phone at 501-906-3000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.